Clinical Trials In San Francisco

Discover hundreds of clinical trials in San Francisco.
Search clinical trials in San Francisco by condition or phase.

e.g. Respiratory Diseases

San Francisco•Healthy volunteers: No

Filter results

Results: 2,146

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

San Francisco, Woodland, Walnut Creek, Vallejoshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

Personalized Therapeutic Neuromodulation for Anhedonic Depression

Recruiting

Sponsor:

Stanford University

Location:

Stanford

Code:

NCT05144789

Conditions

Treatment Resistant Depression

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Active TBS-DLPFC

Active TBS-DMPFC

Sham TBS-DLPFC or DMPFC

Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT05208892

Conditions

Postoperative Pain

Opioid Use

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

SZMN block

SZMN block with Dexmedetomidine

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Recruiting

Phase 2

Phase 3

Sponsor:

AMO Pharma Limited

Location:

Palo Alto, Los Angeles, Little Rock, Chicagoshow 6 more

Code:

NCT05004129

Conditions

Congenital Myotonic Dystrophy

Eligibility Criteria

Sex: All

Age: 6 - 45

Healthy Volunteers: Not accepted

Interventions

Tideglusib

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Palo Alto, Birmingham, New Haven, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Prostate Stimulation for Sexual Dysfunction

Recruiting

Sponsor:

Stanford University

Location:

Stanford

Code:

NCT05468931

Conditions

Sexual Dysfunction

Erectile Dysfunction

Delayed Ejaculation

Anorgasmia

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prostate stimulator

Continuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Santa Barbara, San Mateo, Sacramento, La Mesashow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Verastem, Inc.

Location:

San Francisco, Chicago, Boston, Ann Arborshow 5 more

Code:

NCT05669482

Conditions

KRAS Activating Mutation

Metastatic Cancer

Pancreas Cancer

Neoplasms Pancreatic

Malignant Neoplasm of Pancreas

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Recruiting

Phase 3

Sponsor:

Thomas Hope

Location:

San Francisco

Code:

NCT04895631

Conditions

Hyperparathyroidism, Primary

Eligibility Criteria

Sex: All

Age: 13+

Healthy Volunteers: Not accepted

Interventions

18F-Fluorocholine

Positron emission tomography (PET)

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Recruiting

Phase 2

Phase 3

Sponsor:

Takeda

Location:

Santa Ana, Redwood City, Birmingham, Colorado Springsshow 14 more

Code:

NCT05816382

Conditions

Narcolepsy Type 1

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Interventions

TAK-861

e.g. Respiratory Diseases

San Francisco•Healthy volunteers: No

Filter results

Results: 2,146

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

San Francisco, Woodland, Walnut Creek, Vallejoshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

Personalized Therapeutic Neuromodulation for Anhedonic Depression

Recruiting

Sponsor:

Stanford University

Location:

Stanford

Code:

NCT05144789

Conditions

Treatment Resistant Depression

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Active TBS-DLPFC

Active TBS-DMPFC

Sham TBS-DLPFC or DMPFC

Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT05208892

Conditions

Postoperative Pain

Opioid Use

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

SZMN block

SZMN block with Dexmedetomidine

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Recruiting

Phase 2

Phase 3

Sponsor:

AMO Pharma Limited

Location:

Palo Alto, Los Angeles, Little Rock, Chicagoshow 6 more

Code:

NCT05004129

Conditions

Congenital Myotonic Dystrophy

Eligibility Criteria

Sex: All

Age: 6 - 45

Healthy Volunteers: Not accepted

Interventions

Tideglusib

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

Recruiting

Phase 2

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Palo Alto, Birmingham, New Haven, Atlantashow 53 more

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Prostate Stimulation for Sexual Dysfunction

Recruiting

Sponsor:

Stanford University

Location:

Stanford

Code:

NCT05468931

Conditions

Sexual Dysfunction

Erectile Dysfunction

Delayed Ejaculation

Anorgasmia

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prostate stimulator

Continuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Santa Barbara, San Mateo, Sacramento, La Mesashow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Verastem, Inc.

Location:

San Francisco, Chicago, Boston, Ann Arborshow 5 more

Code:

NCT05669482

Conditions

KRAS Activating Mutation

Metastatic Cancer

Pancreas Cancer

Neoplasms Pancreatic

Malignant Neoplasm of Pancreas

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Recruiting

Phase 3

Sponsor:

Thomas Hope

Location:

San Francisco

Code:

NCT04895631

Conditions

Hyperparathyroidism, Primary

Eligibility Criteria

Sex: All

Age: 13+

Healthy Volunteers: Not accepted

Interventions

18F-Fluorocholine

Positron emission tomography (PET)

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Recruiting

Phase 2

Phase 3

Sponsor:

Takeda

Location:

Santa Ana, Redwood City, Birmingham, Colorado Springsshow 14 more

Code:

NCT05816382

Conditions

Narcolepsy Type 1

Eligibility Criteria

Sex: All

Age: 16 - 70

Healthy Volunteers: Not accepted

Interventions

TAK-861